Skip to content
Study details
Enrolling now

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

University of Rochester
NCT IDNCT06956781ClinicalTrials.gov data as of Apr 2026
Target enrollment

200

Study length

about 2.6 years

Ages

8–17

Locations

1 site in NY

What this study is about

Researchers are testing different treatment components to improve pediatric post-traumatic stress disorder (PTSD). The trial will also provide evidence on how these components work. Researchers will compare the components to a psychological placebo and examine their effects alone and in combination with other components.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Bi-lateral Stimulation
  • 2.Participate in Cognitive Processing
  • 3.Participate in Emotion Regulation
  • +2 more

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Mean Change in PTSD Symptoms - Child PTSD Symptom Scale for DSM-5 (CPSS), Mean Change in PTSD Symptoms - Child and Adolescent Trauma Screen (CATS-2), Mean Change in PTSD Symptoms - Clinician Administered PTSD Scale for DSM-5 - Child/Adolescent Version (CAPS-CA)

Secondary: Brain Aging - Magnetic Resonance Imaging (MRI), Change in Network Connectivity - Magnetic Resonance Imaging (MRI), Change in Neural Structure - Magnetic Resonance Imaging (MRI), Change in PTSD Symptom Trajectories - Child PTSD Symptom Scale for DSM-5 (CPSS), Change in PTSD Symptom Trajectories - Child and Adolescent Trauma Screen (CATS-2), Change in PTSD, Mood, Anxiety, and Disruptive Behavior Disorder Symptom Trajectories - Ecological Momentary Assessment (EMA), Changes in Trajectories of C-Reactive Protein (CRP), Changes in Trajectories of Interleukin-6 (IL-6)

Procedures

therapy

Body systems

Psychiatry / Mental Health, Oncology